Delivery Order SPE2DB20D3304-SPE2DB24FW5E3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,075.04 firm fixed-price delivery order is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The ultimate completion date for this award is February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XULANE 150-35 MCG/DAY contraceptive patches to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,622.76 and runs through July 27, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,070.34 firm-fixed-price delivery order is for XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award has an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,486.10, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The $8,922.64 firm fixed-price contract has a completion date of May 25, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, valued at $3,731.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Xulane 150-35 MCG/DAY Patch 3S, a pharmaceutical product. The award has a completion date of February 6, 2024 and is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $7,664.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 5, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,552.68 firm fixed-price delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S medical patches. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to the U.S. military and other federal healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,563.96 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Cencora, Inc. valued at up to $999,999,999.00, which covers a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award for $1,543.83 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of May 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW5E3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,197.36 and is a delivery order for XULANE 150-35 MCG/DAY PATCH 3S. The contract is a firm fixed-price agreement with a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale. The contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 2/5/24 |